INFORMATION FOR
News
In a new study, Yale researchers identified the targets in the human body to which pathogens transmitted by mosquitoes, ticks, and other vectors bind. Their findings, they say, could help address the rising threat of vector-borne diseases, a leading cause of death worldwide.
The Yale PAX LC Trial’s decentralized, participant-centric design makes it more efficient and cost-effective than standard clinical trials, its investigators say.
Mackenzie Bender awarded an NSF
Arya Ökten wins the 3-minute thesis competition
Lisa Korn, MD, PhD, instructor of medicine (rheumatology, allergy and immunology) has been selected to receive the 2024 Iva Dostanic, MD, PhD, Physician-Scientist Trainee Award.
A multidisciplinary team of Yale scientists has received a $4-million federal grant to study the effectiveness of a new vaccine and monoclonal antibody shot designed to prevent respiratory syncytial virus (RSV) in infants.
Richard Edelson, MD: A dermatologist's 'buddy' leads him toward a revolutionary treatment for cancer, infections, and transplants.
A collection of recent studies from YSM
The Marcus Foundation has awarded $13.2 million to Yale School of Medicine, to support a clinical trial that could mark a first step toward a preventive treatment for Parkinson's disease.
Yale's Center for Infection & Immunity, directed by Akiko Iwasaki, PhD, will lead the funded research.
Scientists have identified a short window early in life during which an antibody that might prevent allergies to peanuts and other foods could become a therapeutic target.
Lisa Korn, MD, PhD, instructor of medicine (rheumatology, allergy and immunology) at Yale School of Medicine, received a 2024 American Society for Clinical Investigation Emerging-Generation Award.
It is a substantial achievement for Yale that its early-career faculty secured 10% of these awards. The numbers reflect the efforts of mentors, departments, and programs who ensure that the awardees have the resources needed to launch independent research programs
Yale Diabetes Research Center Soliciting Grant Applications
Yale has made advances that have changed how doctors and patients grapple with diabetes.
A genetic variant that is linked to faster progression of multiple sclerosis (MS) has been identified in a genome-wide association study.
The term post-acute infection syndrome refers to chronic diseases that occur after an acute viral, bacterial, or parasitic infection, including chronic Lyme and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Yale School of Medicine is investigating the many questions surrounding post-acute infection syndromes in its new Center for Infection & Immunity.
An experimental vaccine is designed to protect against a variety of deadly coronaviruses.
The preservation of insulin-producing beta cells is just one of the benefits of teplizumab, also known as Tzield, a phase 3 trial shows.
A new study led by Yale Cancer Center researchers at Yale School of Medicine reveals that a specific population of CD8+ T-cells marked by IL-7R play an important role in better understanding anti-tumor memory.